The rise and (sort of) fall of glucosamine – Rheuma

Share this article:

Share on facebook
Share on google
Share on twitter
Share on linkedin

“The American College of Rheumatology…in its 2019 guideline: “Glucosamine is strongly recommended against in patients with knee, hip, and/or hand OA.” Studies that showed an effect were often sponsored by industry, it said, and those with least bias didn’t show any advantage over a placebo.”

“The Australian Rheumatology Association and Arthritis Australia have both said in a recent statement that glucosamine “does not help people with osteoarthritis”. To make it perfectly clear, “high-quality evidence shows little or no benefit from glucosamine or chondroitin for OA”, Arthritis Australia says on its website.”

“In the US, consumers have bitten back. In the most recent class action, against manufacturer Reckitt Benckiser, the company settled for US$53 million ($75 million) – reportedly “the largest dietary supplement class action settlement ever reached”.

“The California- and New York-based plaintiffs said they bought the glucosamine product, Move Free Advanced, because the packaging said it treated joint pain and stiffness, but independent studies showed that glucosamine and chondroitin, alone or combined, did not in fact improve mobility, pain or quality of life.”


The rise and (sort of) fall of glucosamine – Rheuma

View original post on FB

Posted to FB on 2022-07-01 13:57:35

Leave a Reply

Related Posts: